Clinical Cancer Research · 2004 · 169 citations · 13 references
MedicineOncologyPathologyMolecular OncologyNeoplasiaTumor ProgressionExtracellular MatrixImmunohistochemistryMalignant NeoplasmsMolecular Tumor ProfilingTumor InvasionTumor-stroma InteractionsImmunohistochemical BiomarkersImmunohistochemical DetectionImmunohistochemical MarkersMatrix Metalloproteinase InhibitorsMatrix MetalloproteinasesProteolytic PathwaysTumor Invasion AssessmentTumor Stage Prognosis
PURPOSE: The matrix metalloproteinases (MMPs) are a family of proteolytic enzymes involved in tumor invasion; several individual members of which have been implicated in tumor prognosis. These enzymes and their physiologic inhibitors, the tissue inhibitors of matrix metalloproteinases (TIMPs), act in a coordinated manner to form an integrated system. Therefore, to understand their role in tumor invasion, it is necessary to evaluate them collectively. EXPERIMENTAL DESIGN: In this study all of the major members of the matrix metalloproteinase (MMP-1, MMP-2, MMP-3, MMP-7, MMP-9, MMP-13, MT1-MMP and MT2-MMP)/tissue inhibitor of matrix metalloproteinase (TIMP-1, TIMP-2, and TIMP-3) system have been investigated by immunohistochemistry in a series (n = 90) of stage III (Dukes' C) colorectal cancers. An immunohistochemical score based on the intensity of immunoreactivity and proportion of immunoreactive cells was established for each MMP and TIMP. RESULTS: The MMP/TIMP profile defined by hierarchical cluster analysis of the immunohistochemical score identifies a distinct group of colorectal cancers with poor prognosis (log-rank test, 12.22, P = 0.0005). The median survival time of patients in this survival group was 18 months compared with a median survival of 49 months in the "good" survival group. Multivariate analysis showed that this profile was independently the most significant prognostic factor (P = 0.001). CONCLUSIONS: This study has identified that the MMP/TIMP profile is an independent indicator of poor prognosis in colorectal cancer.
13
Matrix metalloproteinase–1 is associated with poor prognosis in colorectal cancer
Graeme I. Murray, Margaret E. Duncan, Pauline O'Neil et al. · Nature Medicine · 1996 · 447 citations
Medicine, Cancer Biology, Oncology +11
Matrix metalloproteinase–1 is associated with poor prognosis in colorectal cancer
Graeme I. Murray, Margaret E. Duncan, Pauline O'Neil et al. · Nature Medicine · 1996 · 323 citations
Medicine, Cancer Biology, Oncology +11
Tumour markers of prognosis in colorectal cancer
Howard L. McLeod, Graeme I. Murray · British Journal of Cancer · 1998 · 229 citations · Full text
Medicine, Cancer Biology, Oncology +12
Matrix metalloproteinases and their inhibitors in gastric cancer
Graeme I. Murray, M.E. Duncan, Erin Arbuckle et al. · Gut · 1998 · 193 citations · Full text